Isocyanate Antigens and T Cells That Cause Asthma
NCT00005549 · Status: COMPLETED · Type: OBSERVATIONAL
Last updated 2014-03-14
Summary
To investigate whether isocyanate-induced asthma is dependent on isocyanate antigen-driven T-cell mediated, airway inflammation.
Conditions
- Asthma
- Lung Diseases
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
collaborator NIH -
Yale University
lead OTHER
Principal Investigators
-
Adam Wisnewski · Yale University
Eligibility
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1999-01-31
- Primary Completion
- 2007-04-30
- Completion
- 2007-04-30
More Related Trials
-
Blood Lymphocytes in Asthmatics Treated With Therapeutic Proteins
NCT04514926 ·Status: COMPLETED
-
Risk Factors For Asthma in Laboratory Animal Allergy
NCT00005283 ·Status: COMPLETED
-
A Study to Evaluate the Effectiveness and Safety of MEDI-528 in Adults
NCT00968669 ·Status: COMPLETED ·Phase: PHASE2
-
T Cell Cytokine Changes During IL-4 Receptor Treatment for Asthma
NCT00001908 ·Status: COMPLETED
-
Inflammation and Corticosteroid Responsiveness in Severe Asthma
NCT00180661 ·Status: COMPLETED
-
Modification of Allergic Immunologic Response by Leukotriene Antagonists - Ancillary to ACRN IMPACT
NCT00021931 ·Status: COMPLETED
-
T Cell Effector and Regulatory Mechanisms in Asthma
NCT01612936 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Biologicals on Alternative Functions of Eosinophils in Severe Asthma
NCT04520165 ·Status: ACTIVE_NOT_RECRUITING
-
Study of the Mechanisms of Asthma
NCT00595153 ·Status: COMPLETED ·Phase: PHASE1
-
The Effect of Long Term Inhaled Corticosteroids on the Risk of Cardiovascular Morbidities
NCT00959257 ·Status: COMPLETED
-
Study of T-Regulatory Cells in Asthma
NCT02574351 ·Status: COMPLETED
-
Type 2 Innate Lymphoid Cells in Severe Pediatric Asthma
NCT03784781 ·Status: WITHDRAWN
-
Immune Dysregulation in Children and Adults With Asthma
NCT00135681 ·Status: COMPLETED ·Phase: NA
-
Air Pollution, Inflammation, and New Onset Asthma
NCT00241696 ·Status: COMPLETED
-
Histoblood Group Antigens as a Risk Factor of Asthma
NCT00201266 ·Status: COMPLETED
-
Immune Dysfunction in Allergic Asthma
NCT00189228 ·Status: COMPLETED ·Phase: NA
-
Role of microRNAs in T Cell-Driven Inflammation in Asthma
NCT01484691 ·Status: COMPLETED ·Phase: NA
-
Pilot Study to Identify the Mediators and Inflammatory Cell Surface Receptors Involved in Allergic Airway Inflammation
NCT00595491 ·Status: RECRUITING ·Phase: PHASE1
-
Examining Changes in Nasal IL-1 During Acute Asthma Exacerbation in Adolescents
NCT04748055 ·Status: COMPLETED
-
A Study to Evaluate the Safety and Tolerability of the Administration of MEDI-528 When Administered in Multiple Doses to Adults With Mild Persistent Asthma
NCT00507130 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Efficacy Study of Aerosolized Recombinant Human IL-4 Receptor in Asthma
NCT00001909 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess Selected Biomarkers in Subjects Requiring Daily Inhaled Corticosteroids for Persistent Asthma
NCT01334853 ·Status: COMPLETED
-
Factors Involved in Asthma and Airway Inflammation
NCT00001887 ·Status: COMPLETED
-
Immune Interactions in Severe Asthma
NCT02566668 ·Status: COMPLETED
-
Biomarkers in Exhaled Breath From Asthmatic Patients
NCT00635271 ·Status: TERMINATED